Abstract
Wren began intravenous (IV) anesthesia in 1656, using a goose quill and a bladder to inject wine and ale into a dog’s vein. Invention of the hollow needle in 1843 and the hypodermic syringe in 1853 allowed IV administration of drugs. By the 1900s, diverse drugs, including ether, had been given IV for sedation.
Redonnet made the first IV barbiturate, Somnifen, in 1920. Weese and Scharpff synthesized the short-acting hexobarbital in 1932, but the introduction of thiopental by Lundy and Tovell in 1934 provided the greater advance, dominating induction of anesthesia for the next half century. Price suggested in 1960 that thiopental redistribution from brain to muscle, rather than to fat, explained the rapid awakening from thiopental. This work underlay many subsequent pharmacokinetic and pharmacodynamic concepts. Thiopental decreased cerebral metabolism and cerebral blood flow, leading to its use in the 1970s to protect the brain from hypoxic insult. Methohexital, a shorter-acting barbiturate with central nervous system-stimulating properties, was introduced in 1956 and remains a popular anesthetic for electroconvulsive therapy (ECT).
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Dagnino J. Wren, Boyle, and the origins of intravenous injections and the Royal Society of London. Anesthesiology. 2009;111:923–4.
Major DJ. Chirurgia infusoria placidis CL: vivorium dubiis impugnata, cun modesta ad Eadem, Responsione. Kiloni, 1667.
Boulton TB. The development of the syringe. In Essays on the history of anaesthesia. International Congress and Symposium series 213. Royal Society of Medicine. 1996. pp. 79–84.
Wood A. A new method of treating neuralgia by the direct application of opiates into painful joints. Edinburgh Med Surg J. 1855;82:265–81.
Liebreich O. Observations on the action and uses of croton-chloral hydrate. Br Med J. 1873;20:677–713.
Etudes OPC, cliniques sur l’anesthesie chirurgicale par la method des injection de choral dans les veines. Paris: JB Balliere et Fils, 1875.
Kissin I, Wright AJ. The introduction of hedonal: a Russian contribution to intravenous anesthesia. Anesthesiology. 1988;69:242–5.
Burkhardt L. Uber chloroform and aethernarkose durch intravenose injektion. Arch Exper Path Pharmakol. 1909;61:323.
Rood F. Infusion anaesthesia: the use of normal saline as a means of administering ether. Br Med J. 1911;21:974–6.
Noel H, Souttar HS. The anesthetic effects of intravenous injection of paraldehyde. Ann Surg. 1913;57:64–7.
Peck CH, Meltzer SJ. Anesthesia in human beings by intravenous injection of magnesium sulphate. JAMA. 1916;67:1131–3.
Naragawa K. Experimentelle studien uber die intravenose infusions narkose mittels alcohols. J Exp Med. 1921;2:81–126.
Cardot H, Laugier H. Anesthesie par injection intrareineuse d’un mélange alcool-chloroform-solution physiologique chez le chien. C R Seances Soc Biol. 1922;87:889–92.
Dundee JW, McIlroy PD. The history of the barbiturates. Anaesthesia. 1982;37:726–34.
Bardet D. Sur l’utilisation, comme anesthesique general, d’un produit nouveau. le diethyl-diallyl-barbiturate de diethylamine. Bull Gen Ther Med Chir Obstet Pharm. 1921;172:27–33.
Fjelde JH. The production of obstetrical and surgical anaesthesia by the use of barbituric acid compounds. Anesth Analg. 1929;8:40–7.
Fischer E, Mering J von. Uber eine neue klasse von schlafmitteln. Ther Gengenwart. 1903;44:97–101.
Weese H, Scharpff W. Evipan, cin neuartiges Einschlafmittel. Deut Med Wochenschr. 1932;58:1205–7.
Zerfas LG. Sodium amytal and other derivatives of barbituric acid. Brit Med J. 1930;2:897–902.
Lundy JS, Tovell RM. Some of the newer local and general anesthetic agents: methods of their administration. Northwest Med (Seattle). 1934:33:308–11.
Platt TW, Tatum AL, Hathaway HR, Waters RM. Sodium ethyl (alpha-methyl butyl) thiobarbiturate: preliminary experimental and clinical study. Am J Surg. 1936;31:464–6.
Halford FJ. A critique of intravenous anesthesia in war surgery. Anesthesiology. 1943;4:67–9.
Bennetts FE. Thiopentone anaesthesia at Pearl Harbour. BJA. 1995;75:366–8.
Zima O, Von Werder F, Hotovy R. Methylthioethyl-2′-pentyl-thiobarbituric acid sodium (thiogenal), a new short acting anesthetic. Der Anaesthesist. 1954;3:244–5.
Selye H. Anesthetic effects of steroid hormones. Proc Soc Exp Biol Med. 1941;46:116–20.
Eger EI II, Johnson EA, Larson CP. Severinghaus JW: The uptake and distribution of intravenous ether. Anesthesiology. 1962;23:647–50.
Yang XL, Ma HX, Yang ZB, Liu AJ, Luo NF, Zhang WS, Wang L, Jiang XH, Li J, Liu J. Comparison of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology. 2006;104:482–7.
Price HL. A dynamic concept of the distribution of thiopental in the human body. Anesthesiology. 1960;21:40–5.
Pierce EC Jr, Lambertsen CJ, Deutsch S, Chase PE, Linde HW, Dripps RD, Price HL. Cerebral circulation and metabolism during thiopental anesthesia and hyper-ventilation in man. J Clin Invest. 1962;41:1664–71.
Michenfelder JD, Theye RA. Cerebral protection by thiopental during hypoxia. Anesthesiology. 1973;39:510–7.
Etomidate DA. A new intravenous hypnotic. Acta Anaesthesiol Belg. 1974;25:307–15.
Mayer M, Doenicke A, Nebauer AE, Hepting L. Propofol and etomidate-Lipuro for induction of general anesthesia. Hemodynamics, vascular compatibility, subjective findings and postoperative nausea. Anaesthesist. 1996;45:1082–4.
Gooding JM, Corssen G. Effect of etomidate on the cardiovascular system. Anesth Analg. 1977;56:717–9.
Thuillier MJ, Domenjoz R. Pharmacology of intravenous short anesthesia with 2-methoxy-4-allylphenoxyacetic acid-N, N-diethylamide (G 29505). Anaesthesist. 1957;6:163–7.
Davis B, Pearce DR. An introduction to Althesin (CT 1341). Postgrad Med J. 1972;48:13–7.
Savege TM, Ramsay MA, Curran JP, Cotter J, Walling PT, Simpson BR. Intravenous anaesthesia by infusion. A technique using alphaxolone/alphadolone (Althesin). Anaesthesia. 1975;30:757–64.
Tang J, Qi J, White PF, Wang B, Wender RH. Eltanolone as an alternative to propofol for ambulatory anesthesia. Anesth Analg. 1997;85:801–7.
Collins VJ, Gorospe CA, Rovenstine EA. Intravenous non-barbiturate non-narcotic analgesics: Preliminary Studies. 1. Cyclohexylamines. Anesth Analg. 1960;39:302–6.
Camilleri JG. The use of phencyclidine (C1-395) in obstetric procedures. A preliminary communication. Anaesthesia. 1962;17:422–6.
Domino EF, Chodoff P, Corssen G. Pharmacologic effects of CI-581: a new disscoiative anesthetic in man. Clin Pharmacol Ther. 1965;6:279–91.
Corssen G, Miyasaka M, Domino EF. Changing concepts in pain control during surgery: dissociative anesthesia with CI-581. A progress report. Anesth Analg. 1968;47:746–59.
White PF, Johnston RR, Pudwill CR. Interaction of ketamine and halothane in rats. Anesthesiology. 1975;42:179–86.
White PF, Ham J, Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology. 1980;52:231–9.
White PF, Schüttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of 2 ketamine isomers. Studies in volunteers. Br J Anaesth. 1985;57:197–203.
White PF, Vasconez LO, Mathes SA, Way WL, Wender LA. Comparison of midazolam and diazepam for sedation during plastic surgery. Plast Reconstr Surg. 1988;81:703–12.
Suzuki M, Tsueda K, Lansing PS, Tolan MM, Fuhrman TM, Ignacio CI, Sheppard RA. Small-dose ketamine enhances morphine-induced analgesia after outpatient surgery. Anesth Analg. 1999;89:98–103.
Blakeley KR, Klein KW, White PF, Trott S, Rohrich RJ. A total intravenous anesthetic technique for outpatient facial laser resurfacing. Anesth Analg. 1998;87:827–9.
Stovner J, Endresen R. Diazepam in intravenous anaesthesia. Lancet. 1965;2:1298–9.
Reves JG, Corssen G, Holcomb C. Comparison of two benzodiazepines for anesthesia induction: midazolam and diazepam. Can Anaesth Soc J. 1978;25:211–4.
White PF. Comparative evaluation of intravenous agents for rapid sequence induction’thiopental, ketamine, and midazolam. Anesthesiology. 1982;57:279–84.
B K, G R. ICI 35 868, a new intravenous induction agent. Acta Anaes Belg. 1977;28:303–16.
Kay B, Stephenson DK. ICI 35868 (Diprivan): a new intravenous anaesthetic. A comparison with Althesin. Anaesthesia. 1980;35:1182–7.
Fragen RJ, Grood PM de, Robertson EN, Booij LH, Crul JF. Effects of premedication on diprivan induction. Br J Anaesth. 1982;54:913–6.
Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control. 2001;29:312–5.
Doze VA, Westphal LM, White PF. Comparison of propofol with methohexital for outpatient anesthesia. Anesth Analg. 1986;65:1189–95.
Doze VA, Shafer A, White PF. Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia. Anesthesiology. 1988;69:63–71.
Prys-Roberts C. Practical and pharmacological implications of continuous intravenous anesthesia. Acta Anaesthesiol Belg. 1980;31:225–30.
Alvis JM, Reves JG, Govier AV, Menkhaus PG, Henling CE, Spain JA, Bradley E. Computer-assisted continuous infusions of fentanyl during cardiac anesthesia: comparison with a manual method. Anesthesiology. 1985;63:41–9.
White M, Kenny G. Intravenous propofol anaesthesia using a computerised infusion system. Anaesthesia. 1990;45:204–9.
Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology. 1988;69:348–56.
Sakai T, Matsuki A, White PF, Giesecke AH. Use of an EEG-bispectral closed-loop delivery system for administering propofol. Acta Anaesthesiol Scand. 2000;44:1007–10.
Gan TJ, Glass PS, Windsor A, Payne F, Rosow C, Sebel P, Manberg P. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. Anesthesiology. 1997;87:808–15.
White PF, Negus JB. Sedative infusions during local and regional anesthesia: a comparison of midazolam and propofol. J Clin Anesth. 1991;3:32–9.
Ghouri AF, Ruiz MA, White PF. Effect of flumazenil on recovery after midazolam and propofol sedation. Anesthesiology. 1994;81:333–9.
Song D, Hamza MA, White PF, Byerly SI, Jones SB, Macaluso AD. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care. Anesthesiology. 2004;100:1072–5.
Urquhart ML, White PF. Comparison of sedative infusions during regional anesthesia–methohexital, etomidate, and midazolam. Anesth Analg. 1989;68:249–54.
Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia. 1984;39:973–81.
Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med. 1984;310:1415–21.
Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology. 1984;61:647–51.
Cotten JF, Forman SA, Laha JK, Cuny GD, Husain SS, Miller KW, Nguyen HH, Kelly EW, Stewart D, Liu A, Raines DE. Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function. Anesthesiology. 2010;112:637–44.
Doenicke A, Kugler J, Mayer M, Angster R, Hoffmann P. Ketamine racemate or S-(+)-ketamine and midazolam. The effect on vigilance, efficacy and subjective findings. Anaesthesist. 1992;41:610–8.
White PF, Way WL, Trevor AJ. Ketamine’its pharmacology and therapeutic uses. Anesthesiology. 1982;56:119–36.
Ghouri AF, Ruiz MA, White PF. Effect of flumazenil on recovery after midazolam and propofol sedation. Anesthesiology. 1994;81:333–9.
Laborit H, Huguenard P. Pratique de l’hibernotherapie en chirurgie et medicine. Paris: Masson; 1954. pp. 267–71.
DeCastro G, Mundeleer P, Bauduin T. Crtical evaluation of ventilation and acid-base balance during neuroleptanalgesia. Ann Anaesthesiol Fr. 1964;5:425–36.
Spoerel WE, Chan WS. Innovar in surgical anaesthesia. Can Anaesth Soc J. 1965;12:622–33.
White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg. 2002;95:789–90.
Ekman A, Lindholm ML, Lennmarken C, Sandin R. Reduction in the incidence of awareness using BIS monitoring. Acta Anaesthesiol Scand. 2004;48:20–6.
Myles PS, Leslie K, McNeil J, Forbes A, Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004;363:1757–63.
Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008;358:1097–108.
Sá Rêgo MM, Watcha MF, White PF. The changing role of monitored anesthesia care in the ambulatory setting. Anesth Analg. 1997;85:1020–36.
White PF, Bovill JG. From SIVA to ISAP!’a logical evolution. Anesth Analg. 2001;92:1–2.
Shafer SL, Gambús PL. Inhalation versus intravenous anesthesia: a fictitious debate between E.I. Eger II and P.F. White. J Clin Anesth. 1996;8:38S–41S.
White PF, Editor. Textbook of intravenous anesthesia. Baltimore: Williams & Wilkins; 1997. pp 1–617.
Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology. 1994;81:1005–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Edmond I Eger, MD
About this chapter
Cite this chapter
White, P. (2014). A History of Intravenous Anesthesia. In: Eger II, E., Saidman, L., Westhorpe, R. (eds) The Wondrous Story of Anesthesia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8441-7_47
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8441-7_47
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8440-0
Online ISBN: 978-1-4614-8441-7
eBook Packages: MedicineMedicine (R0)